Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Liverpool, United Kingdom

Liverpool, L7 8YA, United KingdomNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Diabetic eye disease

Running trials

Active, not recruiting
A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME
NCT06571045· Phase 2/3· EyeBiotech Ltd.· Source

Site data: ClinicalTrials.govUpdated 11 Nov 2026

Report an error

Under construction, not live – Liverpool, United Kingdom: trial site – Frontlight Research